A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The purpose of this study is to evaluate if study drug mirikizumab is safe and effective compared to vedolizumab and placebo in participants with moderately to severely active ulcerative colitis (UC).
Epistemonikos ID: 83e90dbaa50f7caa29de3d491736761acf907253
First added on: Mar 23, 2022